Electroacupuncture for Menstrual‐Related Migraine: Protocol for a Multicenter Single‐Blinded Randomized Controlled Trial
Pain Research and Management · 2026-01 · 2026 (1)
DOI: 10.1155/prm/2200276 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pain Research and Management, online erschienen am 20.07.2026. Verfasst von Shihan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Medicine Center, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China, longhua.net. Hauptthemen laut MEDLINE: Electroacupuncture, Migraine Disorders, Menstruation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, Construction of Traditional Chinese Medicine Inheritance and Innovation Development Demonstration Pilot Projects in Pudong New Area-High-Level Research-Oriente…, Shanghai Hospital Development Center.
Abstract (Originalsprache)
Importance Menstrual‐related migraine (MRM) is a prevalent neurological condition affecting females, with prolonged duration, severe symptoms, and poor drug response, significantly impairing their quality of life. Electroacupuncture shows promise as a nonpharmacological intervention for migraine. However, there is a deficiency in high‐quality evidence‐based research assessing its efficacy in MRM. To address this gap, we present a detailed protocol to evaluate electroacupuncture’s therapeutic effects in MRM. Methods and Analysis A total of 120 participants with MRM will be randomly divided into two groups (1:1): the electroacupuncture group and the sham electroacupuncture group. Participants will receive 30‐min treatments (electroacupuncture or sham) for 6 sessions every 4 weeks (18 sessions over 12 consecutive weeks). The primary outcome will be migraine days and attacks during Weeks 9–12 vs. baseline. Secondary outcomes (all vs. baseline unless specified) include the following: (1) frequency‐related: migraine days/attacks per 4 weeks (Weeks 1–24, excluding Weeks 9–12; and during menstrual/nonmenstrual periods). (2) Symptom characteristics: days/attacks with migraine‐associated symptoms and attack duration per 4 weeks. (3) Patient‐reported: visual analog scale (VAS), Migraine Disability Assessment (MIDAS) questionnaire, Insomnia Severity Index (ISI), Generalized Anxiety Disorder‐7 (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9). (4) Others: treatment response rate, average dosage, and frequency of emergency drugs. All adverse events during the research will be documented. SAS 9.4 statistical software will be used for analyses. Trial and Dissemination Ethical approval was obtained from the Medical Ethics Committee of LongHua Hospital Shanghai University of Traditional Chinese Medicine (No. 2024LCSY150), Shanghai Gongli Hospital of Pudong New Area (GLYY1s2024‐085), and Shanghai Municipal Hospital of Traditional Chinese Medicine (2025SHL‐KY‐60‐01), and the study was registered with the International Traditional Medicine Clinical Trials Registry. All participants who fulfill the inclusion criteria and consent to join the study will sign a written informed consent form before randomization. Trial Registration: International Traditional Medicine Clinical Trials Registry: ITMCTR2024000795
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sleep Medicine Center, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China, longhua.net.
- Encephalopathy Department, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China, longhua.net.
- Neurological Department, Shanghai Gongli Hospital of Pudong New Area, Shanghai, China.
- Acupuncture Department, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn.
ORCID-Profile: Shihan Jiang, Qing Ye, Sichun Gu, Qiang Li, Qi Jin, Zhicheng Guo, Ping Yin, Lumin Liu
Förderung
- Shanghai Municipal Health Commission
- Construction of Traditional Chinese Medicine Inheritance and Innovation Development Demonstration Pilot Projects in Pudong New Area-High-Level Research-Oriente…
- Shanghai Hospital Development Center
Zitieren
APA
Jiang, S., Ye, Q., Gu, S., Li, Q., Jin, Q., Guo, Z., Yin, P., & Liu, L. (2026). Electroacupuncture for Menstrual‐Related Migraine: Protocol for a Multicenter Single‐Blinded Randomized Controlled Trial. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/2200276
Vancouver
Jiang S, Ye Q, Gu S, Li Q, Jin Q, Guo Z, et al. Electroacupuncture for Menstrual‐Related Migraine: Protocol for a Multicenter Single‐Blinded Randomized Controlled Trial. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/2200276
BibTeX
@article{Jiang2026,
author = {Jiang, Shihan and Ye, Qing and Gu, Sichun and Li, Qiang and Jin, Qi and Guo, Zhicheng and Yin, Ping and Liu, Lumin},
title = {Electroacupuncture for Menstrual‐Related Migraine: Protocol for a Multicenter Single‐Blinded Randomized Controlled Trial},
journal = {Pain Research and Management},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/prm/2200276}
}
EUVIMED